JP2001518484A5 - - Google Patents

Download PDF

Info

Publication number
JP2001518484A5
JP2001518484A5 JP2000514534A JP2000514534A JP2001518484A5 JP 2001518484 A5 JP2001518484 A5 JP 2001518484A5 JP 2000514534 A JP2000514534 A JP 2000514534A JP 2000514534 A JP2000514534 A JP 2000514534A JP 2001518484 A5 JP2001518484 A5 JP 2001518484A5
Authority
JP
Japan
Prior art keywords
carnitine
composition
especially acid
propionyl
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000514534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001518484A (ja
Filing date
Publication date
Priority claimed from IT97RM000594A external-priority patent/IT1295408B1/it
Application filed filed Critical
Publication of JP2001518484A publication Critical patent/JP2001518484A/ja
Publication of JP2001518484A5 publication Critical patent/JP2001518484A5/ja
Pending legal-status Critical Current

Links

JP2000514534A 1997-10-03 1998-09-18 アルコール中毒者の禁断症状とアルコールに対する渇望を抑制するための、および、健康な人のアルコールの濫用を防ぐための組成物 Pending JP2001518484A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97A000594 1997-07-04
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
PCT/IT1998/000249 WO1999017623A1 (en) 1997-10-03 1998-09-18 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects

Publications (2)

Publication Number Publication Date
JP2001518484A JP2001518484A (ja) 2001-10-16
JP2001518484A5 true JP2001518484A5 (enExample) 2006-01-05

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000514534A Pending JP2001518484A (ja) 1997-10-03 1998-09-18 アルコール中毒者の禁断症状とアルコールに対する渇望を抑制するための、および、健康な人のアルコールの濫用を防ぐための組成物

Country Status (27)

Country Link
US (1) US6255346B1 (enExample)
EP (1) EP1022960B1 (enExample)
JP (1) JP2001518484A (enExample)
KR (2) KR100530368B1 (enExample)
CN (1) CN1092939C (enExample)
AT (1) ATE220860T1 (enExample)
AU (1) AU730740B2 (enExample)
BG (1) BG64363B1 (enExample)
BR (1) BR9812604A (enExample)
CA (1) CA2305598C (enExample)
CZ (1) CZ291801B6 (enExample)
DE (1) DE69806788T2 (enExample)
DK (1) DK1022960T3 (enExample)
EA (1) EA002177B1 (enExample)
EE (1) EE04036B1 (enExample)
ES (1) ES2180200T3 (enExample)
HU (1) HUP0004336A3 (enExample)
IS (1) IS2234B (enExample)
IT (1) IT1295408B1 (enExample)
MX (1) MXPA00003232A (enExample)
NO (1) NO20001688L (enExample)
NZ (1) NZ503663A (enExample)
PL (1) PL189663B1 (enExample)
PT (1) PT1022960E (enExample)
SK (1) SK283384B6 (enExample)
UA (1) UA66807C2 (enExample)
WO (1) WO1999017623A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
RU2300376C2 (ru) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Способ лечения при алкогольном делирии
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) * 2020-04-14 2023-05-18 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
DK0793962T3 (da) * 1996-03-04 2000-05-22 Sigma Tau Ind Farmaceuti Lægemiddel indeholdende et carnitinderivat til behandling af arteriosclerosis obliterans

Similar Documents

Publication Publication Date Title
EP1216024B1 (en) Formulation for menopausal women
JP2001518484A5 (enExample)
US5561160A (en) Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
US6217898B1 (en) Pharmaceutical composition comprising carnitine or alkanoyl L-carnitine, for the prevention and treatment of diseases brought about by lipid metabolism disorders
JP2904788B2 (ja) 高い生物学的利用能をもつ鉄‐カルシウムミネラル補給物
EP2073821B1 (en) Mixture of iron and copper salts masking metallic taste
JP2002518437A (ja) 骨粗鬆症および、更年期症候群による変容の予防および/または治療のための、プロピオニルl−カルニチンおよびゲニステインを含む組成物
JP2009511515A (ja) 金属の味をマスキングする鉄および銅塩の混合物
EP0405295B1 (en) Improved nutritional formulation for the treatment of renal disease
CA2387787A1 (en) Nutritional composition for treating inflammatory bowel diseases
JP2006506361A5 (enExample)
EP1355540B1 (en) Food supplement with a slimming effect
JP2001518484A (ja) アルコール中毒者の禁断症状とアルコールに対する渇望を抑制するための、および、健康な人のアルコールの濫用を防ぐための組成物
AU2001270980A1 (en) Food supplement with a slimming effect
US20040048925A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
JPS58165774A (ja) 飲料組成物
US20040220266A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
JP2006505499A5 (enExample)
CA2478674A1 (en) Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia
US20200254009A1 (en) Potassium enriched topical formulations for pain relief and sleep aid
JP2002512613A (ja) L−カルニチン又はアルカノイル−l−カルニチンコリン酒石酸塩を含む、経口投与に適した固体組成物
CA2400959A1 (en) Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10
Bernal et al. Liver triglyceride concentration and body protein metabolism in ethanol-treated rats: Effect of energy and nutrient supplementation
RU2001101931A (ru) Композиция для профилактики и/или лечения остеопороза и изменений, связанных с синдромом менопаузы
CA2492417C (en) Formulation for menopausal women